knowledge -WSS

knowledge

author：fashion 2025-08-26 07:42:50 - browse：6991

Adobe

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available a novel treatment for a deadly condition that’s long been challenging to treat.

In a large trial published last year, the drug, called sotatercept, exceeded expectations in significantly increasing the distance that patients could walk and cutting the risk that their condition would worsen, that they would die, and that they would need new treatments.

Pulmonary arterial hypertension, or PAH, is estimated to occur in 15 to 50 per million people, mostly in women. It’s characterized by a proliferation of cells in the blood vessels that connect the right side of heart to the lungs, making it harder for blood to pass through and leading the heart to have to work harder to pump blood into the lungs. The disease, which causes difficulty breathing, fatigue and dizziness, has a high mortality rate, with one study finding that one-fifth of patients died at around three years after diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Apple Watch's A

leisure time

knowledge

WSS

Making AI in medicine accessible to smaller, and rural hospitals

North Korean leader's powerful sister says warplanes repelled US spy plane

How corporate America is slashing DEI workers amid backlash to diversity programs

Steward Health Care files for bankruptcy

After gene therapy, two congenitally deaf children hear for the first time

Trump seeks lengthy delay of classified docs trial, citing upcoming election

knowledge

knowledge

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

House panel to mark up pandemic

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Researchers on aging grapple with how to calculate biological age

Psychedelics group wrestles with new pharma identity

Researchers on aging grapple with how to calculate biological age

DIEP, the 'gold standard' of breast reconstruction, is under threat

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Medicare proposal to cover medical devices draws a mixed reaction

US intelligence assessment says Iran not currently developing nuclear weapons

hotspot

North Korean leader's powerful sister says warplanes repelled US spy plane

Titanic submersible: What a 'catastrophic implosion' means and what officials found

What nurses really want: sufficient staffing for patient care

How to improve immunocompromised access to mAb treatments

Sen. Bill Cassidy on how to lower drug prices

Trump seeks lengthy delay of classified docs trial, citing upcoming election

knowledge

leisure time

knowledge

explore